Validation of SFRP1 Promoter Hypermethylation in Plasma as a Prognostic Marker for Survival and Gemcitabine Effectiveness in Patients with Stage IV Pancreatic Adenocarcinoma

por Stubbe, Benjamin Emil, Henriksen, Stine Dam, Madsen, Poul Henning, Larsen, Anders Christian, Krarup, Henrik Bygum, Pedersen, Inge Søkilde, Johansen, Martin Nygård, Thorlacius-Ussing, Ole
Publicado 2021

Promoter hypermethylation of SFRP1 as a prognostic and potentially predictive blood-based biomarker in patients with localized pancreatic ductal adenocarcinoma

por Stubbe, Benjamin Emil, Larsen, Anders Christian, Madsen, Poul Henning, Krarup, Henrik Bygum, Pedersen, Inge Søkilde, Lundbye-Christensen, Søren, Hansen, Carsten Palnæs, Hasselby, Jane Preuss, Johansen, Astrid Zedlitz, Thorlacius-Ussing, Ole, Johansen, Julia Sidenius, Henriksen, Stine Dam
Publicado 2023